tradingkey.logo

Avidity Biosciences Ord Shs

RNAM
72.860
0.0000.00%
Close 03/03, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM
You can access the annual and quarterly cash flow statements of Avidity Biosciences Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---169.77M
Net income from continuing operations
---237.10M
Operating gains losses
--1.50M
Other non-cash items
--83.00K
Change in working capital
--22.27M
-Change in prepaid expenses
---2.55M
-Change in other current liabilities
---859.00K
Cash from non-recurring investing activities
Cash from operating activities
---169.77M
Investing cash flow
Net cash from continuing investing activities
--6.40M
Capital expenditures
--6.40M
Net cash flow from disposal of fixed assets
--6.40M
Net cash flow from investment products
--213.62M
Cash from non-current investing activities
Net cash flow from investing activities
--207.22M
Financing cash flow
Cash flow from continuous financing activities
---5.09M
Net cash flow from common stock issuance/repurchase
--7.32M
Proceeds from issuance of warrants
--0.00
Net cash flow from other financing activities
---12.41M
Net cash from non-recurrent financing activities
Net cash from financing activities
---5.09M
Net cash flow
Beginning cash balance
--352.96M
Current period cash flow changes
--32.36M
Effect of exchange rate changes
---1.00K
Ending cash balance
--385.31M
Free cash flow
---176.18M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI